Immunological changes in the MPTP-induced Parkinson's disease mouse model
暂无分享,去创建一个
[1] F. Rougé-Pont,et al. Hemispheric asymmetry in the effects of substantia nigra lesioning on lymphocyte reactivity in mice. , 1992, The International journal of neuroscience.
[2] M. Moal,et al. Early effects of unilateral lesions of substantia nigra on immune reactivity , 1992, Neuroscience Letters.
[3] A. Członkowska,et al. The immunological status in Parkinson's disease. , 1991, Medical laboratory sciences.
[4] A. Duchemin,et al. Preproenkephalin mRNA and Methionine‐Enkephalin Increase in Mouse Striatum After 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Treatment , 1991, Journal of neurochemistry.
[5] J. Langston,et al. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra , 1987, Brain Research.
[6] C. Markham,et al. Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): Behavior, histology, and biochemistry , 1986, Experimental Neurology.
[7] R. Duvoisin,et al. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. , 1984, Science.
[8] D. Jacobowitz,et al. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[9] A. Cunningham,et al. Further improvements in the plaque technique for detecting single antibody-forming cells. , 1968, Immunology.
[10] J. Vaughan,et al. In vitro Cell Migration as a Model for Delayed Hypersensitivity.∗ , 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[11] R. Sandyk. A tribute to Professor Sidney Weinstein on his 70th birthday. , 1992, The International journal of neuroscience.
[12] D. Marić,et al. In vivo modulation of the immune system by enkephalins. , 1990, The International journal of neuroscience.
[13] J. Kan,et al. Sodium diethyldithiocarbamate protects against the MPTP-induced inhibition of immune responses in mice. , 1989, Life sciences.
[14] T. Roszman,et al. Modulation of T‐Suppressor cell activity by central nervous system catecholamine depletion , 1987, Journal of neuroscience research.
[15] W. Markesbery,et al. Neuroimmunomodulation: impairment of humoral immune responsiveness by 6-hydroxydopamine treatment. , 1986, Immunology.
[16] R. Marttila,et al. Immune functions in Parkinson's disease. , 1984, Advances in neurology.
[17] N. Plotnikoff,et al. Enkephalins as immunomodulators. , 1983, International journal of immunopharmacology.